The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: a retrospective study

Table 3 Multivariate Cox proportional hazards model predicting recurrence

Variables	HR	95% CI		P
CA125 doubling	5.10	1.11	23.43	0.036
FIGO stages 3 or 4 vs stage 1 or 2	1.52	0.28	8.30	0.629
Nadir CA125 levels > 10 U/ml	2.86	1.29	6.37	0.010
Residual disease (any vs. nil)	1.06	0.48	2.33	0.893
Cell type (serous vs. other)	1.52	0.55	4.15	0.417

ISSN: 1757-2215